Clinical Trials in North Carolina

Showing 16461-16480 of 20,428 trials

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months

NCT00806546

This study will use an open-label design to evaluate the safety of NP101. Adult subjects who meet the enrollment criteria will be treated with NP101 (sumatriptan succinate iontophoretic transdermal patch) for acute migraine attacks over a 12 month period.

Migraine Disorders

NuPathe Inc.514 participantsStarted Feb 2009

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Irvine, California, United States +28 more locations

COMPLETEDPhase 331 miles

The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine

NCT00724815

This study was a randomized, parallel group, double-blind, placebo controlled design to compare the efficacy and tolerability of NP101 to a placebo iontophoretic transdermal patch. The primary objective of this study was to assess the proportion of subjects who were headache pain free at two hours after patch activation. Key secondary objectives included: 1. The proportion of subjects who were nausea free at two hours after patch activation. 2. The proportion of subjects who were photophobia free at two hours after patch activation. 3. The proportion of subjects who were phonophobia free at two hours after patch activation.

Migraine Disorders

NuPathe Inc.530 participantsStarted Jan 2009

Phoenix, Arizona, United States • Little Rock, Arkansas, United States • Newport Beach, California, United States +31 more locations

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months

The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine

Find Trials by Condition in North Carolina

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months

Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation

HIV Prevention Among Latino MSM: Evaluation of a Locally Developed Intervention

Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis

Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults

Feasibility Testing of the Quality-monitoring Tool, Qdact, for the Palliative Care Research Cooperative

A Multicenter Trial Comparing REMICADE (Infliximab) and Placebo in the Prevention of Recurrence in Crohn's Disease (CD) Patients Undergoing Surgical Resection Who Are at an Increased Risk of Recurrence

Evaluating the Effectiveness of a Stepped-Care Approach to Long-Term Weight Loss (The Step-Up Study)

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy

Study of Renal Denervation in Patients With Heart Failure

Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease

Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers

DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis

TearLab Refractive Surgery Dry Eye Study

Selumetinib in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Zidovudine Plus Interleukin-2 and Ganciclovir in Treating Patients With AIDS-Related Primary Central Nervous System Lymphoma

Safety and Efficacy the Medigus SRS Endoscopic Stapling System in Gastroesophageal Reflux Disease (GERD)